Drug Therapy, Bromocriptine
NEJM 301:873-878, Parkes,D., 1979
The Role of Bromocriptine in the Treatment of Parkinsonism
Neurol 29:1077-1083, Fahn,S.,et al, 1979
Reduction in Size of a Pituitary Tumor by Bromocriptine Therapy
NEJM 300:291-293, McGregor,A.M.,et al, 1979
The Prolactinoma Problem
NEJM 300:313-315, Reichlin,S., 1979
Bromocriptine in Parkinson Disease:Further Studies
Neurol 29:363-369, Lieberman,A.N.,et al, 1979
Dopamine-Phenytoin Interaction, A Cause of Hypotension in the Critically Ill
Arch Surg 113:245-249, Bivins,B.A.,et al, 1978
Apomorphine Hydrochloride-Induced Improvement in Huntington's Chorea
Arch Neurol 35:27, Corsini,G.U.,et al, 1978
Lergotrile in the Treatment of Parkinsonism
Neurol 28:699, Klawans,H.L.,et al, 1978
Prolactin-Secreting Tumors & Hypogonadism in 22 Men
NEJM 299:847-852, Carter,J.N.,et al, 1978
Considerations in the Management of Parkinsonism
Neurol 28:5, Fahn,S.,et al, 1978
Comparison Between Lergotrile & Bromocriptine in Parkinsonism
Ann Neurol 3:319, Teychenne,P.F.,et al, 1978
Bromocriptine in Parkinsonism
Arch Neurol 35:503, Lees,A.J.,et al, 1978
The Medical Letter
Bromocriptine, 19:1011977., , 1977
Drug Therapy of Tardive Dyskinesia
NEJM 296:257, Kobayashi,R.M., 1977
Azorean Disease of the Nervous System
NEJM 296:1505, Romanul,F.C.A.,et al, 1977
Successful Use of Bromocriptine in the treatment of a Patient with Chronic Portasystemic Encephalopathy
NEJM 296:793, Morgan,M.Y.,et al, 1977
Galactorrhea:A Study of 235 Cases, Including 48 with Pituitary Tumors
NEJM 296:589, Kleinberg,D.L.,et al, 1977
Prolactin-secreting Pituitary Tumors
Ann Neurol 2:148, Antunes,J.L.,et al, 1977
Treatment & Prognosis of Hemiballismus
NEJM 295:1348, Klawans,H.L.,et al, 1976
Serum Dopamine-B-Hydroxylase Activity in Migraine
Arch Neurol 33:656, Gotoh,F.,et al, 1976
Developments in the Treatment of Parkinsonism
NEJM 295:1433, Calne,D.B., 1976
Studies with Bromocriptine Part 2. Double-blind Comparison with Levodopa in Idiopathic Parkinsonism
Neurol 26:511, Kartzinel,R.,et al, 1976
Treatment of Parkinson's Disease with Bromocriptine
NEJM 295:1400, Lieberman,A.,et al, 1976
Anticonvulsant-induced Dyskinesias:A Comparison with Dyskinesias Induced by Neuroleptics
JNNP 39:1210, Chadwick,D.,et al, 1976
Catecholamines & Neurologic Diseases
NEJM 293:274, Moskowitz,M.A.,et al, 1975
Huntington's Chorea-Deficiency of Y-Aminobutynic Acid in Brain
NEJM 288:337, 1973, 289:104, 1973, 292:10295., Perry,T.,et al, 1975
Facial Hyperkinesis
BMJ 626, Jun1974., , 1974
Epidemiology of Motor-Neuron Diseases
NEJM 288:1047, Bobwick,A.R.,et al, 1973
Drug Therapy of Parkinsonism
NEJM 287:20, Yahr,M.,et al, 1972
Implications of Amphetamine-Induced Stereotyped Behavior as a Model for Tardive Dyskinesias
Arch Gen Psychiat 27:502-507, Rubovits,R.,et al, 1972
Cholinergic & Dopaminergic Mechanisms in Huntington's Chorea
Life Sciences 10:405 1971., Aquilonius,S.,et al, 1971
Olivopontocerebellar Atrophies:A Review
Medicine 49:227, Konigsmark,B., 1970
Dopamine & Disease
C M A Journ 103:824, Barbeau,A., 1970
Electrophoretic Morphology of Gamma Globulins in Cerebrospinal Fluid of MS & other Diseases of the CNS
Neurol 20:982, Laterre,E.C.,et al, 1970
Neuropsychopharmcology & the Affective Disorders
NEJM 281:197, 1969 (three parts) ., Schildkraut,J.J., 1969
Progressive Supranuclear Palsy Clinico-Pathological Study of Four Cases
Brain 92:663, Behrman,S.,et al, 1969
Corticodentatonigral Degeneration with Neuronal Achromasia
Arch Neurol 18:20-33, Rebeiz,J.J.,et al, 1968
Tuberous Sclerosis:Reappraisal of a Clinical Entity
Mayo Clin Proc 42:26, Lagos,J.,et al, 1967
Diseases of the Basal Ganglia-Their Relation to Disorders of Movement
Lancet 1099, 1960, Nov., Denny-Brown,D., 1960